卡前列素氨丁三醇治疗宫缩乏力性产后出血临床观察

Clinical Observation on the Treatment of Anemic Postpartum Haemorrhage with Carstoprop Aminobutyl Triol

目的:观察分析宫缩乏力性产后出血患者的治疗过程,总结并阐述卡前列素氨丁三醇对患者的治疗效果。方法:特选取某院接收的宫缩乏力性产后出血患者100例作为研究对象,分为两组各50例,对照组单纯应用缩宫素治疗路径,实验组应用卡前列素氨丁三醇联合缩宫素治疗路径,观察分析两组的治疗效果。结果:治疗前,实验组的出血量为(796.22±15.45)ml,对照组为(6.36±14.45)ml,两组差异不显著,不具有统计学意义(P>0.05);治疗后,实验组的出血量为(73.05±12.63)ml,对照组为(103.15±13.63)ml,实验组明显低于对照组,比较差异具有统计学意义(P<0.05);实验组的治疗有效率为90.0%,对照组为73.3%,实验组的治疗有效率明显优于对照组,两组比较差异有统计学意义(P<0.05)。结论:在宫缩乏力性产后出血患者的治疗中,相比于单纯应用缩宫素治疗路径来说,卡前列素氨丁三醇联合缩宫素治疗路径的治疗效果更为显著,有效降低出血量,安全性高,值得应用。

Objective： To observe and analyze the treatment of patients with anemic postpartum haemorrhage, and to summarize and expound the therapeutic effect of carstoprop aminobutyl triol on patients. Methods： 100 cases of contractive postpartum hemorrhage received by a hospital were selected as the study subjects and divided into two groups. 50 cases in each group.The control group simply used treatment path of pitocin. The experimental group used the treatment path of carstoprop aminobutyl triol combined with pitocin.The therapeutic effect of the two groups was observed. Results： Before treatment, the blood volume of the experimental group was （796.22±15.45） ml, and the control group was （6.36±14.45） ml. The difference between the two groups was not statistically significant （ P 〉0.05）. After treatment, the blood volume of the experimental group was （73.05±12.63） ml, and the control group was （103.15±13.63） ml. The experimental group was significantly lower than the control group, and the difference was statiscally significant （ P 〈0.05）. The therapeutic efficiency of the experimental group was 90.0%; The treatment efficiency of the experimental group was significantly better than that in the control group. The difference between the two groups was statistically significant （ P 〈0.05）. Conclusion： In the treatment of patients with anemic postpartum haemorrhage, comparing with the simple application of pitocin treatment path, carstoprop aminobutyl triol combined with pitocin treatment path is of a more significant effect of treatment,it can effectively reduce the blood loss with high safety,and is worthy of application.